Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE study.
Fiche publication
Date publication
juillet 2015
Journal
BMC cardiovascular disorders
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VERGES Bruno
Tous les auteurs :
Vergès B, Patois-Vergès B, Iliou MC, Simoneau-Robin I, Bertrand JH, Feige JM, Douard H, Catargi B, Fischbach M,
Lien Pubmed
Résumé
Gain in VO2 peak after cardiac rehabilitation (CR) following an acute coronary syndrome (ACS), is associated with reduced mortality and morbidity. We have previously shown in CR, that gain in VO2 peak is reduced in Type 2 diabetic patients and that response to CR is impaired by hyperglycemia.
Mots clés
Acute Coronary Syndrome, complications, Aged, Blood Glucose, metabolism, Diabetes Mellitus, Type 2, complications, Exercise Therapy, methods, Female, Fructosamine, metabolism, Hemoglobin A, Glycosylated, metabolism, Humans, Hypoglycemic Agents, therapeutic use, Insulin Aspart, therapeutic use, Insulin Glargine, therapeutic use, Male, Metformin, therapeutic use, Middle Aged, Oxygen Consumption, Pulmonary Gas Exchange, Pulmonary Ventilation, Treatment Outcome
Référence
BMC Cardiovasc Disord. 2015 Jul;15:64